Since it has been previously shown that the mutations in podocyte INF2 in humans cause FSGS, INF2 associated with varying expression levels of MITF may play a role in this context (Brown et al., 2010; Barua et al., 2013). Here, INF2 is linked to focal segmental glomerulosclerosis.